NCT04120038

Brief Summary

The purpose of this study is to determine the effect of 6 weeks of the SMART Program on the walking capacity and confidence of individuals with unilateral lower limb amputation (LLA). Our primary hypothesis is that SMART can improve walking capacity in individuals with LLA. Our secondary hypothesis is that SMART can improve ambulation confidence, body function, depression, body image, pain, balance confidence, activities of daily living, satisfaction with life and habit formation for skin monitoring and prosthetic cleaning in individuals with LLA. A post-intervention one on one interview will be conducted to understand SMART acceptability. The entirety of the study, including intervention administration, assessment, and interviews will be conducted online.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 9, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 26, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
Last Updated

October 15, 2021

Status Verified

October 1, 2021

Enrollment Period

7 months

First QC Date

October 7, 2019

Last Update Submit

October 7, 2021

Conditions

Keywords

Occupational TherapyRehabilitationLower-Limb AmputationsAmputeesTelehealthRemote RehabilitationTelerehabilitationE-learningEducationSelf-ManagementAmbulationCoping StrategiesOutcomesPrevalence

Outcome Measures

Primary Outcomes (1)

  • Timed Up & Go Test (TUG)

    Functional assessment of walking capacity measured in seconds over 3 meters walkway

    6 weeks

Secondary Outcomes (2)

  • Ambulatory Self-Confidence Questionnaire (ASCQ)

    6 weeks

  • The Center for Epidemiologic Studies Depression Scale (CES-D)

    6 weeks

Other Outcomes (10)

  • Revised Amputee Body Image Scale (ABIS-R)

    6 weeks

  • Pain Questionnaire

    6 weeks

  • Activities Specific Balance Confidence Scale (ABC).

    6 weeks

  • +7 more other outcomes

Study Arms (1)

SMART & Peer Support

EXPERIMENTAL
Device: Self-Management for Amputee Rehabilitation using Technology [SMART]

Interventions

Participants will complete a 6-week tablet-based education program for individuals with LLA that will provide them with self-management education.

SMART & Peer Support

Eligibility Criteria

Age19 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults who are 19 years of age or older.
  • individuals who are post unilateral transtibial/transfemoral amputation and casted an initial prosthesis within the past year.
  • English speaking.
  • living in British Columbia or Ontario, Canada.
  • have access to an internet connectable device (e.g., computer or tablet)

You may not qualify if:

  • \) people who are unable to use SMART program (e.g., visual, auditory, cognitive, or physical impairments)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GF Strong Rehabilitation Centre

Vancouver, British Columbia, V5Z2G9, Canada

Location

Related Publications (1)

  • B Aledi L, Flumignan CD, Trevisani VF, Miranda F Jr. Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD013711. doi: 10.1002/14651858.CD013711.pub2.

Study Officials

  • William C Miller, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 7, 2019

First Posted

October 9, 2019

Study Start

January 26, 2021

Primary Completion

August 31, 2021

Study Completion

August 31, 2021

Last Updated

October 15, 2021

Record last verified: 2021-10

Locations